Back

Tissue specific muscle extracellular matrix hydrogel improves skeletal muscle regeneration in vivo over non-matched tissue source

Ungerleider, J. L.; Dzieciatkowska, M.; Hansen, K. C.; Christman, K. L.

2020-07-01 bioengineering
10.1101/2020.06.30.181164 bioRxiv
Show abstract

Decellularized extracellular matrix (ECM) hydrogels present a novel, clinical intervention for a myriad of regenerative medicine applications. The source of ECM is typically the same tissue to which the treatment is applied; however, the need for tissue specific ECM sources has not been rigorously studied. We hypothesized that tissue specific ECM would improve regeneration through preferentially stimulating physiologically relevant processes (e.g. progenitor cell proliferation and differentiation). One of two decellularized hydrogels (tissue specific skeletal muscle or non mesoderm-derived lung) or saline were injected intramuscularly two days after notexin injection in mice (n=7 per time point) and muscle was harvested at days 5 and 14 for histological and gene expression analysis. Both injectable hydrogels were decellularized using the same detergent and were controlled for donor characteristics (i.e. species, age). At day 5, the skeletal muscle ECM hydrogel significantly increased the density of Pax7+ satellite cells in the muscle. Gene expression analysis at day 5 showed that skeletal muscle ECM hydrogels increased expression of genes implicated in muscle contractility. By day 14, skeletal muscle ECM hydrogels improved muscle regeneration over saline and lung ECM hydrogels as shown through a shift in fiber cross sectional area distribution towards larger fibers. This data indicates a potential role for muscle-specific regenerative capacity of decellularized, injectable muscle hydrogels. Further transcriptomic analysis of whole muscle mRNA indicates the mechanism of tissue specific ECM-mediated tissue repair may be immune and metabolism pathway-driven. Taken together, this suggests there is benefit in using tissue specific ECM for regenerative medicine applications.Competing Interest StatementKLC is co-founder, board member, consultant, receives income, and has equity interest in Ventrix, Inc.View Full Text

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Journal of Biomedical Materials Research Part A
18 papers in training set
Top 0.1%
22.3%
2
npj Regenerative Medicine
21 papers in training set
Top 0.1%
12.2%
3
Acta Biomaterialia
85 papers in training set
Top 0.1%
10.0%
4
Tissue Engineering Part A
15 papers in training set
Top 0.1%
6.3%
50% of probability mass above
5
Advanced Healthcare Materials
71 papers in training set
Top 0.5%
4.3%
6
Biomaterials Science
21 papers in training set
Top 0.2%
3.0%
7
Cytotherapy
14 papers in training set
Top 0.1%
3.0%
8
Stem Cell Research & Therapy
30 papers in training set
Top 0.2%
3.0%
9
Biomaterials
78 papers in training set
Top 0.3%
2.9%
10
Bioengineering & Translational Medicine
21 papers in training set
Top 0.2%
2.7%
11
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 0.8%
2.6%
12
Biomaterials Advances
20 papers in training set
Top 0.2%
2.6%
13
Journal of Orthopaedic Research
19 papers in training set
Top 0.2%
1.7%
14
Biofabrication
32 papers in training set
Top 0.5%
1.7%
15
PLOS ONE
4510 papers in training set
Top 57%
1.5%
16
ACS Biomaterials Science & Engineering
37 papers in training set
Top 0.7%
1.3%
17
Scientific Reports
3102 papers in training set
Top 67%
1.2%
18
Annals of Biomedical Engineering
34 papers in training set
Top 0.9%
1.2%
19
Cellular and Molecular Bioengineering
21 papers in training set
Top 0.2%
0.9%
20
Advanced Functional Materials
41 papers in training set
Top 2%
0.8%
21
Bioactive Materials
18 papers in training set
Top 0.7%
0.7%
22
Cell Reports Medicine
140 papers in training set
Top 9%
0.6%